product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Rat anti Mouse CD169:FITC
catalog :
MCA947F
quantity :
0.1 mg
price :
316 USD
clonality :
monoclonal
host :
rat
conjugate :
FITC
clone name :
MOMA-1
reactivity :
mouse
application :
immunohistochemistry, immunocytochemistry, immunohistochemistry - frozen section
more info or order :
citations: 6
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry - frozen section; mouse; loading ...; fig 5e
Tsai F, Homan P, Agrawal H, Misharin A, Abdala Valencia H, Haines G, et al. Bim suppresses the development of SLE by limiting myeloid inflammatory responses. J Exp Med. 2017;214:3753-3773 pubmed publisher
  • immunohistochemistry; mouse; 1:100; fig 4
Kishimoto M, Matsuda T, Yanase S, Katsumi A, Suzuki N, Ikejiri M, et al. Rhof promotes murine marginal zone B cell development. Nagoya J Med Sci. 2014;76:293-305 pubmed
  • immunohistochemistry - frozen section; mouse; 1:100; fig 8
Matsuda T, Yanase S, Takaoka A, Maruyama M. The immunosenescence-related gene Zizimin2 is associated with early bone marrow B cell development and marginal zone B cell formation. Immun Ageing. 2015;12:1 pubmed publisher
Tamburini B, Burchill M, Kedl R. Antigen capture and archiving by lymphatic endothelial cells following vaccination or viral infection. Nat Commun. 2014;5:3989 pubmed publisher
O CONNOR T, Frei N, Sponarova J, Schwarz P, Heikenwalder M, Aguzzi A. Lymphotoxin, but not TNF, is required for prion invasion of lymph nodes. PLoS Pathog. 2012;8:e1002867 pubmed publisher
Chen J, Limon J, Blanc C, Peng S, Fruman D. Foxo1 regulates marginal zone B-cell development. Eur J Immunol. 2010;40:1890-6 pubmed publisher
image
image 1 :
Bio-Rad MCA947F image 1
Published customer image: . AlexaFluor 647 conjugated Rat anti Mouse CD169 antibody, clone MOMA-1 used to demonstrate marginal zone metallophils by immunofluorescence. Image caption: . DCIR2 + cDCs migrate from the marginal zone bridging channel to the T cell zone after immunization. Spleens from BALB/c mice (n = 2 per time point) immunized with 250 ug IgE anti-OVA pre-mixed with 100 ug OVA or with 100 ug OVA alone were harvested after 0.5, 4, 8, 24, or 48 h. One unimmunized mouse (Nil) was used as control. (a–k) Half of each spleen was snap-frozen and non-consecutive spleen sections were stained and analyzed by confocal microscopy. Localization of DCIR2 + cDCs in spleens harvested at indicated time points after immunization was followed. B220 + B cells, blue; CD169 + metallophilic macrophages, grey; DCIR2 + cDCs, red. Marginal zone bridging channels are indicated with arrows in (a,g). Images show representative areas (640 um × 640 um) of 3–4 T cell zones from 2 non-consecutive sections of each sample in every group. Scale bar represents 100 um. Data represent one experiment where mice were immunized with IgE-OVA or OVA alone and one where they were immunized with IgE-OVA. (l) The other halves of the spleens from mice immunized with IgE-OVA complexes in (a–e) were prepared into single cell suspensions and 6 × 10 5 cells were used as APCs in co-cultures with 10 5 CFSE-labeled CD4 + T cells isolated from DO11.10 splenocytes. Percentages of divided cells among OVA-specific CD4+ T cells after incubation for 3 days with APCs taken from an unimmunized mouse (Nil) or from mice immunized with IgE-OVA complexes are quantified by flow cytometry as shown in Fig. 3. CD4 + T cells cultured alone were used as negative control. Each circle represents one mouse and the lines represent the mean values. From: Ding Z, Dahlin JS, Xu H, Heyman B. IgE-mediated enhancement of CD4(+) T cell responses requires antigen presentation by CD8 (-) conventional dendritic cells. Sci Rep. 2016 Jun 16;6:28290 .
product information
Entity Type :
Monoclonal Antibody
Entity Category :
Antibodies
ProductCode :
MCA947F
Description :
Rat anti Mouse CD169:FITC
Specificity :
CD169
TargetSpecies :
Mouse
Host :
Rat
Format :
FITC
Conjugate/Tag :
FITC
Isotypes :
IgG2a
Applications :
C,IF
ApplicationTypes :
Immunohistology - Frozen,Immunofluorescence
Cross Reactivities :
Human,Rat
Clone :
MOMA-1
Quantity :
0.1 mg
Quantity Value :
0.1
Quantity Type :
mg
GO Accessions :
GO:0005886,GO:0005515,GO:0007155,GO:0016021,GO:0005576,GO:0005529,GO:0006897
GOTerms :
plasma membrane,protein binding,cell adhesion,integral to membrane,extracellular region,sugar binding,endocytosis
Uniprot Accessions :
Q62230
Gene :
Siglec1
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=20612
Published Synonyms :
Sialoadhesin
Entity Formats :
FITC,Purified
UNSPSC :
41116161
Concentration :
IgG concentration 0.1 mg/ml
Product Form :
Purified IgG conjugated to Fluorescein Isothiocyanate Isomer 1 (FITC) - liquid
PriceGBP :
225
PriceEUR :
316
PriceUSD :
316 USD
PriceCHF :
344
PriceSEK :
3444
PriceNOK :
3462
PriceDKK :
2356
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.